Showing results (21-30 of 199) with videos related to
Sort By:
Pageof 20
Nuclear Medicine and Biology|August 1, 1997
Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging resultsR K Hom, J A KatzenellenbogenBiochemical and Biophysical Research Communications|August 15, 1991
Halo enol lactone inhibitors of chymotrypsin: burst kinetics and enantioselectivity of inactivationD J Baek, J A KatzenellenbogenBioorganic & Medicinal Chemistry Letters|January 5, 1999
Ligands for the estrogen receptor, containing cyclopentadienyltricarbonylrhenium unitsT W Spradau, J A KatzenellenbogenBioconjugate Chemistry|January 20, 1999
Integrated "3+1" oxorhenium(V) complexes as estrogen mimicsM B Skaddan, J A KatzenellenbogenJournal of Medicinal Chemistry|September 1, 1988
Optimizing of 2,3-diarylindenes as fluorescent estrogens: variation of the acceptor group, ortho substitution of the 2-ring, and C-1 methylationG M Anstead, J A KatzenellenbogenChemistry & Biology|July 1, 1996
Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responsesJ A Katzenellenbogen, B S KatzenellenbogenThe Journal of Biological Chemistry|January 5, 1991
Proline-valine pseudo peptide enol lactones. Effective and selective inhibitors of chymotrypsin and human leukocyte elastaseP E Reed, J A KatzenellenbogenBioorganic & Medicinal Chemistry|May 20, 2000
Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptorS H Kim, J A KatzenellenbogenMolecular Endocrinology (Baltimore, Md.)|February 27, 2001
Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and releaseA C Gee, J A KatzenellenbogenSteroids|May 1, 1995
Synthesis of C-6 fluoroandrogens: evaluation of ligands for tumor receptor imagingY S Choe, J A KatzenellenbogenPageof 20